Hormonal
In Type-2 diabetes patients, elevated BMI, fasting plasma glucose, insulin resistance, and triglycerides are independent risk factors for developing nonalcoholic fatty liver disease (NAFLD).
If you have Type-2 Diabetes, managing your liver health requires looking beyond just blood sugar. You must actively monitor and manage your Triglycerides, Insulin Resistance, and Body Weight. High levels of any of these significantly increase your risk of developing fatty liver, so regular lipid panels and insulin sensitivity checks are critical components of your diabetes care.
logistic regression analysis showed a higher BMI (OR=1.841, P=0.013), FPG (OR=1.576, P=0.014), insulin resistance (OR=4.195, P<0.001) and elevated TG (OR=4.676, P=0.042) are risk factors for T2DM with NAFLD.
Why this rating
Retrospective observational study with a small sample size (n=145) and single-center design.
Source
Clinico-pathological features and related risk factors of Type-2 diabetes mellitus complicated with nonalcoholic fatty liver
Lisha Chen et al. · Pakistan Journal of Medical Sciences · 2022
DOI 10.12669/pjms.38.7.6289
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →